SGS Group Management SA sell "Biosafety Testing"

Life-saving medicines face heavy regulation during development, manufacture, and distribution, driving demand for independent service providers offering comprehensive characterization at a single site. SGS's global center of excellence for cell bank characterization and virus testing, based in the United Kingdom, delivers services built on GLP/cGMP quality and scientific expertise. As early developers of the biosafety testing field, the Glasgow team has developed and validated novel nucleic acid technologies such as real-time PCR, RAPD, sequencing, non-radioactive Southern blotting, and next-generation sequencing, helping biologics developers meet global regulatory guidelines and testing requirements.